“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
With close to one-third of adults in the United States choosing to delay or forego the experimental COVID-19 vaccines, the medical industry is reportedly trying to understand the reasons behind the hesitancy and figure out how to persuade more Americans to get vaccinated.
Story Highlights Christopher Exley, PhD has hundreds of peer-reviewed articles and a well-established international reputation for his expertise on the toxicity and neurotoxicity of aluminum in the brain. In a study published in 2021, he and his colleagues investigating aluminum toxicity demonstrated that the amount of aluminum in vaccines varies and differs significantly from amounts […]
On June 2, 2021, the Israeli Ministry of Health announced that it believes there is a “probable link” between Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19 and dozens of cases of myocarditis (inflammation of the heart) in Israel—mostly in males between 16-30 years of age. According to an epidemiological study undertaken by a […]
Hundreds of thousands of British citizens marched in central London on May 29, 2021 in a “Unite for Freedom” rally to protest against the government’s COVID-19 lockdowns, vaccine passports and other pandemic-related regulations and restrictions.1 2 Chanting “no more lockdowns” and “take your freedom back,” protesters later gathered at the Westfield shopping center, which was […]
The European Medicines Agency (EMA) held an emergency meeting on Mar. 18, 2021 after many European countries suspended use of the Oxford/AstraZeneca experimental COVID-19 vaccine due to reports of severe side effects including blood clots, low platelet counts and death.1 The EMA conducted a preliminary investigation into potential serious side effects and pronounced the vaccine […]
On Nov. 26, 2020, when I raised questions1 about the results of Pfizer’s and Moderna’s COVID-19 vaccine trials, all that was in the public domain were the study protocols2 and a few press releases.3 Now, two journal publications4 and around 400 pages of summary data are available in the form of multiple reports presented by and to the U.S. Food and Drug […]
Only two weeks after the first experimental biologic for SARS-CoV-2 became available, the U.S. was more than 16 millions doses behind Operation Warp Speed’s goal of giving COVID-19 vaccines to 20 million people by the end of 2020.1 Responding to the slow rollout, Operation Warp Speed chief adviser Moncef Slaoui, MD proposed giving half-doses to […]
There appears to be a consensus opinion among leading public health authorities that a coronavirus vaccine for COVID-19 would take at least 12-18 months to develop, test and be ready for market distribution. The projection assumes that an aggressive development schedule would produce a licensed vaccine proven safe and effective for use in humans no […]
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of the single-dose oral cholera vaccine Vaxchora, developed by multinational biopharmaceutical firm Emergent BioSolutions, Inc. of Gaithersburg, Maryland. On Jan. 30, 2020, the CHMP adopted a “positive opinion” on the granting of a marketing authorization for the bacterial […]
In July 2019, drug and French vaccine manufacturer Sanofi signed a deal with Roche Pharmaceuticals to obtain exclusive over-the-counter (OTC) rights for Tamiflu (oseltamivir), an antiviral drug licensed for the treatment of influenza infections. Genentech, a member of the Roche Group, currently sells Tamiflu in the United States only for prescription use.1 Tamiflu is a […]